Wednesday 28 January 2015



Drug- Tobacco Interactions





 S.no
Product
Interactions (TOBACCO)
1.        
ALPRAZOLAM
Concurrent use of ALPRAZOLAM and TOBACCO may result in decreased alprazolam plasma concentrations and efficacy
2.        
CONTRACEPTIVES , COMBINATION
Concurrent use of CONTRACCEPTIVES, COMBINATION and TOBACCO may result in an increased risk of cardiovascular disease.
3.        
ERLOTINIB
Concurrent use of ERLOTINIB and TOBACCO may result in increased erlotinib clearance and reduced serum concentrations.
4.        
FLUVOXAMINE
Concurrent use of  FLUVOXAMINE and TOBACCO may result in increased fluvoxamine metabolism
5.        
IMIPRAMINE
Concurrent use of IMIPRAMINE  and TOBACCO may result in decreased imipramine concentrations
6.        
PENTAZOCINE
Concurrent use of PENTAZOCINE  and TOBACCO may result in decreased Pentazocine  concentrations
7.        
PROPOXYPHENE
Concurrent use of PROPOXYPHENE and TOBACCO may result in decreased Propoxyphene  concentrations
8.        
ROPINIROLE
Concurrent use of ROPINIROLE  and TOBACCO may result in decreased Ropinirole plasma concentrations and efficacy
9.        
THEOPHYLLINE
Concurrent use of THEOPHYLLINE and TOBACCO may result in decreased Theophylline concentrations
10.    
TOLBUTAMIDE
Concurrent use of TOLBUTAMIDE and TOBACCO may result in decreased tolbutamide concentrations
11.    
WARFARIN
Concurrent use of  WARFARIN and TOBACCO may result in increased or decreased prothrombin time

No comments:

Post a Comment